These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

191 related items for PubMed ID: 26536211

  • 1. Hormonal contraceptive use and women's risk of HIV acquisition: priorities emerging from recent data.
    Ralph LJ, Gollub EL, Jones HE.
    Curr Opin Obstet Gynecol; 2015 Dec; 27(6):487-95. PubMed ID: 26536211
    [Abstract] [Full Text] [Related]

  • 2. Risk of HIV-1 acquisition among women who use diff erent types of injectable progestin contraception in South Africa: a prospective cohort study.
    Noguchi LM, Richardson BA, Baeten JM, Hillier SL, Balkus JE, Chirenje ZM, Bunge K, Ramjee G, Nair G, Palanee-Phillips T, Selepe P, van der Straten A, Parikh UM, Gomez K, Piper JM, Watts DH, Marrazzo JM, VOICE Study Team.
    Lancet HIV; 2015 Jul; 2(7):e279-87. PubMed ID: 26155597
    [Abstract] [Full Text] [Related]

  • 3. Hormonal contraception and the risk of HIV acquisition among women in South Africa.
    Morrison CS, Skoler-Karpoff S, Kwok C, Chen PL, van de Wijgert J, Gehret-Plagianos M, Patel S, Ahmed K, Ramjee G, Friedland B, Lahteenmaki P.
    AIDS; 2012 Feb 20; 26(4):497-504. PubMed ID: 22156973
    [Abstract] [Full Text] [Related]

  • 4. Prospective study of hormonal contraception and women's risk of HIV infection in South Africa.
    Myer L, Denny L, Wright TC, Kuhn L.
    Int J Epidemiol; 2007 Feb 20; 36(1):166-74. PubMed ID: 17175547
    [Abstract] [Full Text] [Related]

  • 5. Hormonal contraception and the risk of HIV acquisition: an individual participant data meta-analysis.
    Morrison CS, Chen PL, Kwok C, Baeten JM, Brown J, Crook AM, Van Damme L, Delany-Moretlwe S, Francis SC, Friedland BA, Hayes RJ, Heffron R, Kapiga S, Karim QA, Karpoff S, Kaul R, McClelland RS, McCormack S, McGrath N, Myer L, Rees H, van der Straten A, Watson-Jones D, van de Wijgert JH, Stalter R, Low N.
    PLoS Med; 2015 Jan 20; 12(1):e1001778. PubMed ID: 25612136
    [Abstract] [Full Text] [Related]

  • 6. Hormonal contraceptive methods and risk of HIV acquisition in women: a systematic review of epidemiological evidence.
    Polis CB, Phillips SJ, Curtis KM, Westreich DJ, Steyn PS, Raymond E, Hannaford P, Turner AN.
    Contraception; 2014 Oct 20; 90(4):360-90. PubMed ID: 25183264
    [Abstract] [Full Text] [Related]

  • 7. Hormonal contraception and HIV acquisition risk: implications for individual users and public policies.
    Jain AK.
    Contraception; 2012 Dec 20; 86(6):645-52. PubMed ID: 22541635
    [Abstract] [Full Text] [Related]

  • 8. Pharmacokinetic, biologic and epidemiologic differences in MPA- and NET-based progestin-only injectable contraceptives relative to the potential impact on HIV acquisition in women.
    Heffron R, Achilles SL, Dorflinger LJ, Hapgood JP, Kiarie J, Polis CB, Steyn PS.
    Contraception; 2019 Apr 20; 99(4):199-204. PubMed ID: 30576636
    [Abstract] [Full Text] [Related]

  • 9. Effects of injectable contraception with depot medroxyprogesterone acetate or norethisterone enanthate on estradiol levels and menstrual, psychological and behavioral measures relevant to HIV risk: The WHICH randomized trial.
    Singata-Madliki M, Smit J, Beksinska M, Balakrishna Y, Avenant C, Beesham I, Seocharan I, Batting J, Hapgood JP, Hofmeyr GJ.
    PLoS One; 2024 Apr 20; 19(3):e0295764. PubMed ID: 38530848
    [Abstract] [Full Text] [Related]

  • 10. Comparison of Female Genital Tract Cytokine and Microbiota Signatures Induced by Initiation of Intramuscular DMPA and NET-EN Hormonal Contraceptives - a Prospective Cohort Analysis.
    Dabee S, Tanko RF, Brown BP, Bunjun R, Balle C, Feng C, Konstantinus IN, Jaumdally SZ, Onono M, Nair G, Palanee-Phillips T, Gill K, Baeten JM, Bekker LG, Passmore JS, Heffron R, Jaspan HB, Happel AU.
    Front Immunol; 2021 Apr 20; 12():760504. PubMed ID: 34956191
    [Abstract] [Full Text] [Related]

  • 11. The injectable contraceptives depot medroxyprogesterone acetate and norethisterone enanthate substantially and differentially decrease testosterone and sex hormone binding globulin levels: A secondary study from the WHICH randomized clinical trial.
    Avenant C, Singata-Madliki M, Bick AJ, Africander D, Balakrishna Y, Storbeck KH, Moliki JM, Dlamini S, Skosana S, Smit J, Beksinska M, Beesham I, Seocharan I, Batting J, Hofmeyr GJ, Hapgood JP.
    PLoS One; 2024 Apr 20; 19(8):e0307736. PubMed ID: 39178280
    [Abstract] [Full Text] [Related]

  • 12. Effects of hormonal contraceptive use on HIV acquisition and transmission among HIV-discordant couples.
    Lutalo T, Musoke R, Kong X, Makumbi F, Serwadda D, Nalugoda F, Kigozi G, Sewankambo N, Sekasanvu J, Wawer M, Gray R.
    AIDS; 2013 Oct 20; 27 Suppl 1():S27-34. PubMed ID: 24088681
    [Abstract] [Full Text] [Related]

  • 13. Bone mineral density in women aged 40-49 years using depot-medroxyprogesterone acetate, norethisterone enanthate or combined oral contraceptives for contraception.
    Beksinska ME, Smit JA, Kleinschmidt I, Farley TM, Mbatha F.
    Contraception; 2005 Mar 20; 71(3):170-5. PubMed ID: 15722065
    [Abstract] [Full Text] [Related]

  • 14. Preexposure prophylaxis is efficacious for HIV-1 prevention among women using depot medroxyprogesterone acetate for contraception.
    Heffron R, Mugo N, Were E, Kiarie J, Bukusi EA, Mujugira A, Frenkel LM, Donnell D, Ronald A, Celum C, Baeten JM, Partners PrEP Study Team.
    AIDS; 2014 Nov 28; 28(18):2771-6. PubMed ID: 25493602
    [Abstract] [Full Text] [Related]

  • 15. Depo Provera. Position paper on clinical use, effectiveness and side effects.
    Bigrigg A, Evans M, Gbolade B, Newton J, Pollard L, Szarewski A, Thomas C, Walling M.
    Br J Fam Plann; 1999 Jul 28; 25(2):69-76. PubMed ID: 10454658
    [Abstract] [Full Text] [Related]

  • 16. Progestin-only injectables offer many advantages.
    Finger WR.
    Netw Res Triangle Park N C; 1995 Jun 28; 15(4):16-20. PubMed ID: 12289828
    [Abstract] [Full Text] [Related]

  • 17. Hormonal contraceptive use and women's risk of HIV acquisition: a meta-analysis of observational studies.
    Ralph LJ, McCoy SI, Shiu K, Padian NS.
    Lancet Infect Dis; 2015 Feb 28; 15(2):181-9. PubMed ID: 25578825
    [Abstract] [Full Text] [Related]

  • 18. Statement on injectable contraception.
    International Planned Parenthood Federation IPPF.
    IPPF Med Bull; 1982 Dec 28; 16(6):3-4. PubMed ID: 12338511
    [Abstract] [Full Text] [Related]

  • 19. Use of injectable hormonal contraception and women's risk of herpes simplex virus type 2 acquisition: a prospective study of couples in Rakai, Uganda.
    Grabowski MK, Gray RH, Makumbi F, Kagaayi J, Redd AD, Kigozi G, Reynolds SJ, Nalugoda F, Lutalo T, Wawer MJ, Serwadda D, Quinn TC, Tobian AAR.
    Lancet Glob Health; 2015 Aug 28; 3(8):e478-e486. PubMed ID: 26094162
    [Abstract] [Full Text] [Related]

  • 20. Hormonal Contraception and HIV-1 Acquisition: Biological Mechanisms.
    Hapgood JP, Kaushic C, Hel Z.
    Endocr Rev; 2018 Feb 01; 39(1):36-78. PubMed ID: 29309550
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.